Conney, A.H., Y.R. Lou, J.G. Xie, T. Osawa, H.L. Newmark, Y. Liu, R.L. Chang, and M.T. Huang (1997). “Some Perspectives on Dietary Inhibition of Carcinogenesis: Studies with Curcumin and Tea.” Proc Soc Exp Biol Med216: 234—45.
4.
Deshpande, S.S., A.D. Ingle, and G.B. Maru (1998). “Chemopreventive Efficacy of Curcumin-Free Aqueous Turmeric Extract in 7,12-dimethylbenz(a)nthracene-induced Rat Mammary Tumorigenesis.” Cancer Lett123: 35—40.
5.
Garnick, M.B. (1993). “Prostate Cancer: Screening, Diagnosis, and Management.” Ann Intern Med118: 804—18.
6.
Hanif, R., L. Qiao, S.J. Shiff, and B. Rigas (1997). “Curcumin, A Natural Plant Phenolic Food Additive, Inhibits Cell Proliferation and Induces Cell Cycle Changes in Colon Adenocarcinoma Cell Lines by a Prostaglandin-Independent Pathway.” J Lab Clin Med130: 576—84.
7.
Ho, C.-T. (1992). Antioxidants and Cancer Prevention. Phenolic Compounds in Food and their Effect on Health II. M.-T. Huang, C.-T. Ho, and C. Y. Lee. ACS Symposium Series 507; American Chemical Society: Washington, DC.
8.
Huang, M.-T., T. Lysz, T. Ferraro, T.F. Abidi, J.D. Laskin, and A.H. Conney (1991a). “Inhibitory Effects of Curcumin on In Vitro Lipoxygenase and Cyclooxygenase Activities in Mouse Epidermis.” Cancer Res51: 813—9.
9.
Huang, M.-T., T. Lysz, T. Ferraro, T.F. Abidi, J.D. Laskin, and A.H. Conney (1991b). Cancer Res51: 813—9.
10.
Huggins, C. and C.V. Hodges (1941). “Studies on Prostate Cancer: I. The Effect of Estrogen and of Androgen Injection on Serum Phosphatase in Metastatic Prostate Cancer.” Cancer Res1: 293—7.
11.
Ikezaki, S., A. Nishikawa, F. Furukawa, K. Kudo, H. Nakamura, K. Tamura, and H. Mori (2001). “Chemopreventive Effects of Curcumin on Glandular Stomach Carcinogenesis Induced by N-methyl-N'-nitro-N-nitrosoguanidine and Sodium Chloride in Rats.” Anticancer Res21: 3407—12.
12.
Inano, H., M. Onoda, N. Inafuku, M. Kubota, Y. Kamada, T. Osawa, H. Kobayashi, and K. Wakabayashi (1999). “Chemoprevention by Curcumin During the Promotion Stage of Tumorigenesis of Mammary Gland in Rats Irradiated with Gamma-Rays.” Carcinogenesis20: 1011—8.
13.
Ireson, C.R., D.J.L. Jones, S. Orr, M.W.H. Coughtrie, D.J. Boocock, M.L. Williams, P.B. Farmer, W.P. Steward, and A.J. Gescher (2002). “Metabolism of the Cancer Chemopreventive Agent Curcumin in Human and Rat Intestine.” Cancer Epidemiol Biomark Prev11: 105—11.
14.
Ireson, C.R., S. Orr, D.J.L. Jones, R. Verschoyle, C.K. Lim, J.L. Luo, L. Howells, S.M. Plummer, R. Jukes, M. Williams, W.P. Steward, and A. Gescher (2001). “Characterization of Metabolites of the Chemopreventive Agent Curcumin in Humans and Rat Hepatocytes and Rat Plasma and Evaluation of Their Ability to Inhibit Phorbol Ester-Induced Prostaglandin E2 Production.” Cancer Res61: 1058—64.
15.
Kumar, A.P., R. Rajnarayanan, G.E. Garcia, A. Adamian, W.L. Alworth, and T.J. Slaga (2002). “Novel Curcumin Derivatives Induces Apoptosis Through Akt-NFκB Signaling in Human Prostate Cancer Cells.” Proc Amer Cancer Soc43: Supplement: Abstract #LB-77; 66.
16.
Lin, J.K., Y.C. Chen, Y.T. Huang, and S.Y. Lin-Shiau (1997). “Suppression of Protein Kinase C and Nuclear Oncogene Expression as Possible Molecular Mechanisms of Cancer Chemoprevention by Apigenin and Curcumin.” J Cell Biochem Suppl 28: 39—48.
17.
Pan, M.H., T.M. Huang, and J.K. Lin (1999). “Biotransformation of Curcumin Through Reduction and Glucouronidation in Mice.” Drug Metab Disp27: 486—94.
18.
Perkins, S., R.D. Verschoyle, K. Hill, I. Parveen, M.D. Threadgill, R.A. Sharma, M.L. Williams, W.P. Steward, and A.J. Gescher (2002). “Chemopreventive Efficacy and Pharmacokinetics of Curcumin in the Min/+ Mouse, A Model of Familial Adenomatous Polyposis .” Cancer Epidemiol Biomark Prev11: 535—40.
19.
Pratt, D.E. (1992). Antioxidants and Cancer Prevention. Phenolic Compounds in Food and their Effect on Health II. M.-T. Huang, C.-T. Ho, and C. Y. Lee. ACS Symposium Series 507; American Chemical Society: Washington, DC.
20.
Rao, C.V., A. Rivenson, B. Simi, and B. Reddy (1995). “Chemoprevention of Colon Carcinogenesis by Dietary Curcumin, a Naturally Occurring Plant Phenolic Compound. ” Cancer Res55: 259—66.
21.
Scher, H.I., G. Steineck, and W.K. Kelly (1995). “Hormone Refractory (D3) Prostate Cancer: Refining the Concept.” Urology46: 142—8.
22.
Sharma, R.A., K.A. Hill, H.R. McLelland, C.R. Ireson, S.A. Euden, M.M. Manson, M. Pirmohamed, L.J. Marnett, A.J. Gescher, and W.P. Steward (2001). “Pharmacodynamic and Pharmacokinetics Study of Oral Curcumin Extract in Patients with Colorectal Cancer.” Clin Cancer Res7: 1834—900.